Patients with end-stage kidney disease initiating dialysis have a high incidence of pulmonary embolism (PE) and substantial mortality.

This cohort study examines the incidence and outcomes of pulmonary embolism as well as anticoagulant use among patients with end-stage kidney disease initiating dialysis.